Marker Therapeutics, Inc. COM NEW

Marker Therapeutics, Inc. COM NEW is a security (CUSIP 57055L206) tracked across SEC portfolio filings. 34 institutional managers reported $5.0M on Form 13F as of 2026-06-30; 1 registered fund positions totaling $166K via N-PORT as of 2026-03-31.

Summary

Top institutional holders (Form 13F)

Showing 15 of 34 managers by value.

ManagerLocationValueShares
NEA Management Company, LLCTIMONIUM, MD$2.1M1,625,678
Blue Owl Capital Holdings LPNew York, NY$721K554,250
VANGUARD GROUP INCValley Forge, PA$516K346,074
Aisling Capital Management LPNEW YORK, NY$423K325,370
RENAISSANCE TECHNOLOGIES LLCNEW YORK, NY$228K175,294
GEODE CAPITAL MANAGEMENT, LLCBOSTON, MA$209K160,910
OSAIC HOLDINGS, INC.PHOENIX, AZ$121K93,121
LPL Financial LLCFORT MILL, SC$108K83,047
Concurrent Investment Advisors, LLCTampa, FL$100K67,963
XTX Topco LtdLONDON, X0$83K63,567
TWO SIGMA INVESTMENTS, LPNew York, NY$79K61,001
SUSQUEHANNA INTERNATIONAL GROUP, LLPBALA CYNWYD, PA$63K48,780
JANE STREET GROUP, LLCNEW YORK, NY$47K36,303
UBS Group AGZurich, V8$42K32,369
Invst, LLCINDIANAPOLIS, IN$38K29,000

Top fund holders (N-PORT)

FundRegistrantValue% of fund
VANGUARD EXTENDED MARKET INDEX FUNDVANGUARD INDEX FUNDS$166K0.02%

More